David J. Nutt

Some important changes
J Psychopharmacol 2004 18: 5. [PDF]  

H. J. Gijsman, A. F. Cohen, and J. M. A Van Gerven

The Application of the Principles of Clinical Drug Development to Pharmacological Challenge Tests of the Serotonergic System
J Psychopharmacol 2004 18: 7-13. [Abstract] [PDF] [References]  

Ian M. Anderson

Drug Information Not Regulation is Needed
J Psychopharmacol 2004 18: 14-15. [PDF] [References]  

Jayne E. Bailey

The Application of Good Clinical Practice to Challenge Tests
J Psychopharmacol 2004 18: 16. [PDF] [References]  

Roger M. Pinder

The Application of the Principles of Clinical Drug Development to a Pharmacological Challenge Test of the Serotonergic System
J Psychopharmacol 2004 18: 17. [PDF] [References]  

H. J. Gijsman, A. F. Cohen, and J. M. A. van Gerven

Reply to Anderson, Bailey, Pinder
J Psychopharmacol 2004 18: 18-19. [PDF] [References]  

Cathy Matrenza, Jay-Maree Hughes, Andrew H. Kemp, Keith A. Wesnes, Ben J. Harrison, and Pradeep J. Nathan

Simultaneous Depletion of Serotonin and Catecholamines Impairs Sustained Attention in Healthy Female Subjects without Affecting Learning and Memory
J Psychopharmacol 2004 18: 21-31. [Abstract] [PDF] [References]  

Ben J. Harrison, James S. Olver, Trevor R. Norman, Graham D. Burrows, Keith A. Wesnes, and Pradeep J. Nathan

Selective Effects of Acute Serotonin and Catecholamine Depletion on Memory in Healthy Women
J Psychopharmacol 2004 18: 32-40. [Abstract] [PDF] [References]  

Clementine Maddock, Antonella Baita, M. Germana Orrù, Rossella Sitzia, Alessandra Costa, Elisabetta Muntoni, M. Giulia Farci, Bernardo Carpiniello, and Carmine M. Pariante

Psychopharmacological Treatment of Depression, Anxiety, Irritability and Insomnia in Patients Receiving Interferon-: a Prospective Case Series and a Discussion of Biological Mechanisms
J Psychopharmacol 2004 18: 41-46. [Abstract] [PDF] [References]  

David P. Finn, Alan L. Hudson, Hiroshi Kinoshita, Toni L. Coventry, David S. Jessop, David J. Nutt, and Michael S. Harbuz

Imidazoline2 (I2) Receptor- and 2- Adrenoceptor-Mediated Modulation of Hypothalamic-Pituitary-Adrenal Axis Activity in Control and Acute Restraint Stressed Rats
J Psychopharmacol 2004 18: 47-53. [Abstract] [PDF] [References]  

Javier Corchero, José M. Oliva, Carmen García-Lecumberri, Sonsoles Martin, Emilio Ambrosio, and Jorge Manzanares

Repeated administration with 9- tetrahydrocannabinol regulates µ-opioid receptor density in the rat brain
J Psychopharmacol 2004 18: 54-58. [Abstract] [PDF] [References]  

José M. Oliva, Sergio Ortiz, Tomás Palomo, and Jorge Manzanares

Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain
J Psychopharmacol 2004 18: 59-65. [Abstract] [PDF] [References]  

Markus T. Grauer and Manfred Uhr

P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline
J Psychopharmacol 2004 18: 66-74. [Abstract] [PDF] [References]  

Harry R. Sumnall, Graham F. Wagstaff, and Jon C. Cole

Self-Reported Psychopathology in Polydrug Users
J Psychopharmacol 2004 18: 75-82. [Abstract] [PDF] [References]  

G. M. Davies, P. Willner, D. L. James, and M. J. Morgan

Influence of Nicotine Gum on Acute Cravings for Cigarettes
J Psychopharmacol 2004 18: 83-87. [Abstract] [PDF] [References]  

J. Liappas, T. Paparrigopoulos, P. Malitas, E. Tzavellas, and G. Christodoulou

Mirtazapine Improves Alcohol Detoxification
J Psychopharmacol 2004 18: 88-93. [Abstract] [PDF] [References]  

R. A. Richell and M. Anderson

Reproducibility of Negative Mood Induction: a Self-Referent Plus Musical Mood Induction Procedure and a Controllable/Uncontrollable Stress Paradigm
J Psychopharmacol 2004 18: 94-101. [Abstract] [PDF] [References]  

Leigh J. Beglinger, Brenda L. Gaydos, David A. Kareken, Oranee Tangphao-Daniels, Eric R. Siemers, and Richard C. Mohs

Neuropsychological Test Performance in Healthy Volunteers Before and After Donepezil Administration
J Psychopharmacol 2004 18: 102-108. [Abstract] [PDF] [References]  

J. van der Post, P. P. de Waal, M. L. de Kam, A. F. Cohen, and J. M. A. van Gerven

No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity
J Psychopharmacol 2004 18: 109-114. [Abstract] [PDF] [References]  

Andrew F. Clark

Incidences of New Prescribing by British Child and Adolescent Psychiatrists: a Prospective Study Over 12 Months
J Psychopharmacol 2004 18: 115-120. [Abstract] [PDF] [References]  

R. W. Kerwin, Sarah Osborne, and Ricardo Sainz-Fuertes

Heat Stroke in Schizophrenia During Clozapine Treatment: Rapid Recognition and Management
J Psychopharmacol 2004 18: 121-123. [Abstract] [PDF] [References]  

Rodrigo A. Bressan, Hugh M. Jones, and Lyn S. Pilowsky

Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity
J Psychopharmacol 2004 18: 124-127. [Abstract] [PDF] [References]  

S. Ashim, S. Warrington, and I. M. Anderson

Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implications
J Psychopharmacol 2004 18: 128-132. [Abstract] [PDF] [References]  

C. Corcoran, M. L. Wong, and V. O’Keane

Bupropion in the management of apathy
J Psychopharmacol 2004 18: 133-135. [Abstract] [PDF] [References]  

Subject Index
J Psychopharmacol 2004 18: 136-139. [PDF]  

Author Index
J Psychopharmacol 2004 18: 140-143. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.